Tempus Ai

This study tests whether an artificial intelligence (AI) tool can analyze a simple ECG to detect undiagnosed pulmonary hypertension (high blood pressure in the lungs) in people with interstitial lung disease. About 900 adults with severe lung scarring will be randomly assigned to…

This study looks at whether a simple blood test can find tiny bits of cancer DNA left in the body after breast cancer treatment. Finding this DNA, called minimal residual disease, may help predict if the cancer will come back. The study will follow 900 people with different types…

This study is for 500 adults with cancer who are willing to give extra blood samples over time. Researchers will use these samples to track DNA changes and look for clues that may help predict how cancer behaves. The goal is to gather information, not to test a new treatment.

This study is for people with acute myeloid leukemia (AML) or follicular lymphoma. Researchers will collect blood and leftover tissue samples during routine care to look for genetic markers that may predict how the disease progresses or responds to treatment. The goal is to bette…

This study is for people with non-small cell lung cancer who have had or will have surgery to remove their tumor. Researchers will collect blood samples and health information over time to see how the cancer changes and whether a simple blood test can predict if the cancer will c…

This study is for 500 adults with advanced head and neck squamous cell carcinoma who are starting standard immunotherapy. Researchers will collect blood and tumor samples over time to study genetic and immune markers. The goal is to better understand which patients respond to tre…

This study observes 200 people with extensive stage small cell lung cancer to learn how tumor tissue and blood-based genetic markers relate to treatment outcomes. Participants provide tumor samples and blood tests during standard care. The goal is to better understand cancer subt…